124 related articles for article (PubMed ID: 10530797)
21. KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia.
Park WK; Jeong D; Cho H; Lee SJ; Cha MY; Pae AN; Choi KI; Koh HY; Kong JY
Pharmacol Biochem Behav; 2005 Oct; 82(2):361-72. PubMed ID: 16216322
[TBL] [Abstract][Full Text] [Related]
22. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
[TBL] [Abstract][Full Text] [Related]
23. Effects of the novel antipsychotic agent 7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro -2(1H)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary gland.
Inoue T; Domae M; Yamada K; Furukawa T
J Pharmacol Exp Ther; 1996 Apr; 277(1):137-43. PubMed ID: 8613910
[TBL] [Abstract][Full Text] [Related]
24. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
25. Identification, purification, and partial characterization of a factor from rabbit serum that inhibits prolactin secretion by pituitary cells cultured in vitro.
Giacomelli S; Cheng CY; Leone MG; Palmery M; Silvestrini B
Biochem Mol Biol Int; 1997 Sep; 42(6):1199-213. PubMed ID: 9305538
[TBL] [Abstract][Full Text] [Related]
26. Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats.
Jelovac N; Sikiric P; Rucman R; Petek M; Marovic A; Perovic D; Seiwerth S; Mise S; Turkovic B; Dodig G; Miklic P; Buljat G; Prkacin I
Eur J Pharmacol; 1999 Aug; 379(1):19-31. PubMed ID: 10499368
[TBL] [Abstract][Full Text] [Related]
27. EGYT-2509 a novel neuroleptic agent without extrapyramidal and endocrine side effects.
Gacsályi I; Petöcz L; Fekete MI; Bükkfálvi B; Görgenyi F; Arató M
Pol J Pharmacol Pharm; 1988; 40(6):613-9. PubMed ID: 2908364
[TBL] [Abstract][Full Text] [Related]
28. The sigma receptor ligand rimcazole alters secretion of prolactin and alpha-melanocyte stimulating hormone by dopaminergic and non-dopaminergic mechanisms.
Eaton MJ; Lookingland KJ; Moore KE
Eur J Pharmacol; 1996 Mar; 299(1-3):171-7. PubMed ID: 8901020
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effects of substituted benzamides and standard neuroleptics on the binding of 3H-spiroperidol in the rat pituitary and striatum with in vivo effects on rat prolactin secretion.
Meltzer HY; So R; Miller RJ; Fang VS
Life Sci; 1979 Aug; 25(7):573-83. PubMed ID: 41148
[No Abstract] [Full Text] [Related]
30. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: II. Functional profile in comparison to clozapine and haloperidol.
Millan MJ; Schreiber R; Dekeyne A; Rivet JM; Bervoets K; Mavridis M; Sebban C; Maurel-Remy S; Newman-Tancredi A; Spedding M; Muller O; Lavielle G; Brocco M
J Pharmacol Exp Ther; 1998 Sep; 286(3):1356-73. PubMed ID: 9732399
[TBL] [Abstract][Full Text] [Related]
31. The posterior pituitary: regulation of anterior pituitary prolactin secretion.
Peters LL; Hoefer MT; Ben-Jonathan N
Science; 1981 Aug; 213(4508):659-61. PubMed ID: 7256264
[TBL] [Abstract][Full Text] [Related]
32. Effects of growth hormone-releasing factor, somatostatin and dopamine on growth hormone and prolactin secretion from cultured ovine pituitary cells.
Law GJ; Ray KP; Wallis M
FEBS Lett; 1984 Jan; 166(1):189-93. PubMed ID: 6141070
[TBL] [Abstract][Full Text] [Related]
33. In vivo potencies of antipsychotic drugs in blocking alpha 1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of action.
Cohen BM; Lipinski JF
Life Sci; 1986 Dec; 39(26):2571-80. PubMed ID: 2879204
[TBL] [Abstract][Full Text] [Related]
34. Evidence for a coupling of prolactin secretion and synthesis by rat pituitary cells in culture.
Ponsin G; Rousset B; Mornex R
Biochim Biophys Acta; 1982 Nov; 721(3):297-304. PubMed ID: 6816296
[TBL] [Abstract][Full Text] [Related]
35. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
[TBL] [Abstract][Full Text] [Related]
36. Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.
Ninan I; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):603-8. PubMed ID: 10669905
[TBL] [Abstract][Full Text] [Related]
37. Resumption of prolactin secretion after dopaminergic inhibition: differential effects of dopamine and its agonists.
Woolf PD
Am J Physiol; 1981 Jun; 240(6):E700-4. PubMed ID: 7246736
[TBL] [Abstract][Full Text] [Related]
38. Perlapine: relationship between stimulation of prolactin secretion and antipsychotic activity.
Meltzer HY; Fessler RG; Fang VS
Psychopharmacology (Berl); 1977 Oct; 54(2):183-6. PubMed ID: 412213
[TBL] [Abstract][Full Text] [Related]
39. Competitive antagonism of serotonin (5-HT)2C and 5-HT2A receptor-mediated phosphoinositide (PI) turnover by clozapine in the rat: a comparison to other antipsychotics.
Canton H; Verrièle L; Millan MJ
Neurosci Lett; 1994 Nov; 181(1-2):65-8. PubMed ID: 7898773
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of acute administration of haloperidol and clozapine on ethanol-induced ascorbic acid release in rat striatum.
Liu W; Wu CF; Liu J; Huang M; Xiao K
Eur J Pharmacol; 2000 Jun; 398(3):333-9. PubMed ID: 10862822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
